Frontlight ResearchEarly access
Trial site
Tianjin Medical Unversity Second Hospital
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Prostate cancer2 trials
- Melanoma1 trial
- Phase
- Phase 22 trials
- Phase 1/21 trial
- Status
- Recruiting3 trials
- Lead sponsor
- Tianjin Medical University Second Hospital3 trials
Running trials
Recruiting
Phase II Trial of Tunlametinib in Patients With NRAS Mutant Non-melanoma Refractory Solid Tumors
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Prostate cancer2 recruiting
- Melanoma1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026